Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × ivosidenib × Clear all

NCT06593548 2024-09-19

Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer

Phase 2 Not yet recruiting

Neoplasm Metastasis